Keya Medical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keya medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keya Medical Today - Breaking & Trending Today

On-site FFR-CT using machine learning reduces invasive procedures in stable CAD

NEW ORLEANS — In patients with stable CAD, use of CT-derived fractional flow reserve with on-site machine learning reduced invasive coronary angiography in those who did not need it, but did not improve other outcomes, researchers reported.For the TARGET trial, presented at the American College of Cardiology Scientific Session and simultaneously published in Circulation, the researchers ....

United States , Brianb Ghoshhajra , Richard Smith , Siemens Healthineers , Byerik Swain , Yundai Chen , Troy Labounty , American College Of Cardiology Scientific Session , Clinical Research , Harvard Medical School , American College , Cardiology Scientific Session , New Orleans , Philips Healthcare , Keya Medical , Seattle Angina Questionnaire , Massachusetts General Hospital ,

Kunlun Capital Helps Medical Companies Grow in the Long Run

/PRNewswire/ Recently, Yahui Zhou, the founding partner of Kunlun Capital, won the 36kr 2022 " China 100 Best Investors Voted by Entrepreneurs " award and. ....

Yahui Zhou , Life Technologies Limited , Kunlun Capital , Investors Voted , Venture Capital Voted , Venture Capital , Kunlun Investment , Keya Medical , Life Technologies ,

Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines


Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines
News provided by
Share this article
Share this article
SHANGHAI, March 11, 2021 /PRNewswire/ Delonix Bioworks Ltd. (Delonix), a biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, has recently closed a $14 million Series Seed financing led by Boehringer Ingelheim Venture Fund (BIVF) and IDG Capital, with participation from ZhenFund and an undisclosed investor. The financing will be used to accelerate the building of synthetic biology vaccine platforms and advance pipelines of synthetic vaccines to clinical trials.
Based in Shanghai, China, Delonix is working on innovative synthetic biology approaches to develop the next generation medical solutions to address global public health challenges. Delonix s synthetic biology and antigen discovery platforms enable rational design and p ....

Weiyi Zhang , Bob Xiaoping Xu , Colortech Bio , Delonix Bioworks , Qiubin Lin , Victor Qiang Wang , Boehringer Ingelheim Venture Fund Gmb , Delonix Bioworks Ltd , Boehringer Ingelheim Venture Fund , Stage Investment Firm , Prnewswire Delonix Bioworks Ltd , Series Seed , Managing Director , Zixuan Pang , Vice President , Boehringer Ingelheim Venture Fund Gmbh , Ping An Good Doctor , Analytical Biosciences , Zhenge Biotech , Microtech Medical , Keya Medical , Accutar Biotech , Sequoia Capital , Stage Investment , வெற்றியாளர் கியாங் வாங் , போஹெரிங்கர் இஂகல்‌ஹைம் துணிகர நிதி க்ம்ப் ,